EN DE

Esthetics International Group (5081) Fair Value & Analysis

Consumer Defensive · MY · Market cap 42.7M MYR (≈ $10.6M) · ISIN MYL5081OO004

EI Esthetics International Group 5081 · KLSE
Price0.1800 MYR
Fair Value0.1300 MYR
Upside-27.8%
Quality63/100
Watch Esthetics International Group for free, get notified when fair value or trend changes. Watch for free

Strengths

Low debt · generates free cash flow

Risks

!Trades 38% ABOVE our fair value of 0.1300 MYR
!Mixed Growth (revenue 5y +8.5 %/yr)
!Loss-making · -1.7% net margin
!Mixed vs. peers (6/12)
Mixed Growth (revenue 5y +8.5 %/yr)
Loss-making · -1.7% net margin
Low debt · generates free cash flow
Mixed vs. peers (6/12)
Narrow moat 20/100
Evidence: High Range 0.1200 MYR – 0.1400 MYR Share as image

Fair value as of: Aug 28, 2026

From 16 valuation models · updated yesterday

Share price −5.3% over the past month.

A solid business, but trading 38% above our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Esthetics International Group and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card. Track it free

What matters now

  • The price sits above even our optimistic bull case (0.1400 MYR). The favourable scenario is already priced in.
  • Solid but not exceptional quality (63/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

0.7825 MYR 0.1750 MYR Fair Value 0.1300 MYR Oct 2015 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 28, 2026.

How to read this chart

60‑month range 0.1750 MYR – 0.7825 MYR · fair‑value band 0.1200 MYR – 0.1400 MYR · the 0.1800 MYR price screens above the 0.1300 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 28, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Esthetics International Group (5081) currently trades at 0.1800 MYR, while our model-based Fair Value estimate is 0.1300 MYR, implying the stock looks roughly 27.8% overvalued today. The Quality Score stands at 63/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Esthetics International Group generated revenue of 195M MYR at a net margin of -1.7%. Revenue grew 4.1% year over year. It earns a return on equity of -2.3%. Fundamentals as of Aug 28, 2026

Our scenario range runs from 0.1200 MYR (bear case) to 0.1400 MYR (bull case); at 0.1800 MYR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -37% fair-value upside, at -28%, 5081 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 1.16 MYR 1.44 MYR 1.76 MYR 80
Rev-Margin DCF 0.5800 MYR 0.6500 MYR 0.7400 MYR 74
ROIC Compounder 0.1000 MYR 0.1000 MYR 0.1000 MYR 72
All 16 models by family
DCF Models
FCF DCF 1.15 MYR 1.47 MYR 1.84 MYR 38
Owner Earnings 0.6600 MYR 0.8400 MYR 1.04 MYR 31
5Y Revenue Exit 0.5800 MYR 0.6300 MYR 0.6700 MYR 39
5Y EBITDA Exit 1.04 MYR 1.45 MYR 1.90 MYR 41
10Y Revenue Exit 0.8300 MYR 0.9200 MYR 1.01 MYR 36
10Y EBITDA Exit 1.08 MYR 1.40 MYR 1.77 MYR 37
Earnings-Based
EPV 0.1000 MYR 0.1000 MYR 0.1000 MYR 59
Dividend Discount
Gordon GGM 0.0300 MYR 0.0500 MYR 0.0700 MYR 70
DDM Multi-Stage 0.0300 MYR 0.0500 MYR 0.0600 MYR 61
Multiples
EV/EBIT 0.1200 MYR 0.1300 MYR 0.1400 MYR 53
EV/EBITDA 1.08 MYR 1.41 MYR 1.74 MYR 54
EV/Revenue 0.1200 MYR 0.1200 MYR 0.1300 MYR 43
Asset-Based
NCAV (Graham) 0.3100 MYR 0.4100 MYR 0.6100 MYR 50
Growth DCF
Growth DCF 1.16 MYR 1.44 MYR 1.76 MYR 80
Rev-Margin DCF 0.5800 MYR 0.6500 MYR 0.7400 MYR 74
Economic Profit
ROIC Compounder 0.1000 MYR 0.1000 MYR 0.1000 MYR 72

Widest divergence: DCF Models (0.9200 MYR) versus Dividend Discount (0.0500 MYR). Highest evidence: Growth DCF (80).

Notify me when 5081 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/S ratio 0.22 TTM
EPS (TTM) -0.0100 MYR
Net margin -1.7% FY2026
Return on equity -2.3% TTM
Return on assets (EBIT) -1.1% avg 5y
Operating margin -0.3% TTM
More key figures
Growth
Revenue (TTM) 195M MYR TTM
Revenue growth (YoY) +4.1% 3y avg +5.7%
EPS growth (YoY) +74.0%
Balance sheet & cash flow
Free cash flow 31.6M MYR FY2026

Figures from reported company fundamentals · as of Aug 28, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 63/100

Of which business quality 62 · Market factors (momentum, volatility) 34

Profitability 31
Margins and returns on capital today
Quality Growth 62
Are margins and returns improving?
Cashflow 77
Earnings quality: real cash, not paper profit
Fin. Strength 46
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 25
Price trend over the last 3–12 months (market factor)
52W Momentum 11
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Esthetics International Group Berhad, an investment holding company, operates as a beauty and wellness company in Malaysia, Singapore, Hong Kong, Indonesia, and Thailand. It operates through Professional Services and Sales, Product Distribution, E-Commerce, and Others segments.

Full company description

Esthetics International Group Berhad, an investment holding company, operates as a beauty and wellness company in Malaysia, Singapore, Hong Kong, Indonesia, and Thailand. It operates through Professional Services and Sales, Product Distribution, E-Commerce, and Others segments. The company distributes skincare products, haircare products, hair tools, makeup products, aromatherapy products, and skin care equipment under Davines, GHD, Jane Iredale, Tisserand, and Dermalogica brands. It also develops and distributes daily enzyme drink under the Bioxil Innertreats brand; and fast-moving consumer goods skin care products under the Clinelle and Nurish Organiq brands. In addition, the company operates beauty and wellness centers; provides beauty and wellness services, as well as education and training in beauty and wellness, and management services; operates as an agent for trademarks and patents applications; retails beauty and wellness products through e-commerce; and invests in properties. Further, it owns and operates corporate outlets comprising AsterSpring skin care salons, and retail stores and department store counters. The company distributes its products through independent professional skincare, haircare salons, medispas, and aesthetic clinics. The company was incorporated in 1996 and is headquartered in Shah Alam, Malaysia. Esthetics International Group Berhad is a subsidiary of Providence Capital Sdn Bhd.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Esthetics International Group reported revenue of 195M MYR in FY2026 versus 125M MYR in FY2022, a compound +11.8%/yr. Reported net income was −3.3M MYR in FY2026.

Growth Quality 54/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2026)
195M MYR
Latest YoY
+6.2%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.7%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.5%
Avg. revenue growth/yr (14Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.8%
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed
Revenue +11.8%/yr
FY22 125M MYR
FY23 165M MYR
FY24 179M MYR
FY25 184M MYR
FY26 195M MYR
Net income
FY22 −6.1M MYR
FY23 −5.7M MYR
FY24 −1.6M MYR
FY25 −8.9M MYR
FY26 −3.3M MYR

5081 screens 28% overvalued. Compare with L'Oréal S.A →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Esthetics International Group Fair Value". https://www.fairvalue-calculator.com/stock/5081

Peer Group

Household & Personal Products · 252 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 63 · Above median
Fair Value upside −28% · Below median
Return on assets 0% · Bottom 25%
Net margin (TTM) -2% · Bottom 25%
Operating margin (TTM) -0% · Bottom 25%
Revenue growth 4% · Above median
Dividend yield (TTM) 2.8% · Above median
Debt / equity 0.09× · Higher than median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/B 0.07× · Cheaper than 75% of peers
P/S (TTM) 0.05× · Cheaper than 75% of peers
P/FCF 0.3× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 29
FUTURE21 · sector 7
PAST0 · sector 27
HEALTH96 · sector 98
DIVIDEND56 · sector 52

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 28, 2026).

Stock Price Fair Value vs Fair Value
L'Oréal S.A LORL C$24.76 C$22.64 -9%
Unilever PLC UNA €55.53 €40.47 -27%
Colgate-Palmolive Company CL $92.06 $55.28 -40%
500696 500696 ₹2,093 ₹641.55 -69%
Hindustan Unilever Limited HINDUNILVR ₹2,015 ₹789.46 -61%
Kenvue Inc KVUE $18.98 $10.97 -42%
Kimberly-Clark Corporation KMB $110.34 $79.71 -28%
Henkel AG HEN3 €75.82 €85.95 +13%
The Estée Lauder Companies Inc ESLA €86.54 €18.84 -78%
Church & Dwight Co CHD $102.86 $65.12 -37%

Compare Esthetics International Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Esthetics International Group (5081) overvalued or undervalued?
As of Aug 28, 2026, our model estimates a fair value of 0.1300 MYR versus a price of 0.1800 MYR, about −28% (overvalued).
What is the fair value of 5081?
Our model-based fair value for Esthetics International Group is 0.1300 MYR (as of Aug 28, 2026), built from audited fundamentals. The current price: 0.1800 MYR.
What is the quality score of 5081?
Esthetics International Group has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Esthetics International Group (5081)?
Esthetics International Group reported trailing-twelve-month revenue of about 195M MYR (latest available figure, as of Aug 28, 2026).
What is the net profit margin of 5081?
The net profit margin of Esthetics International Group is about -1.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free · no account needed

Watch Esthetics International Group in the live analysis

One click puts Esthetics International Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.